
Keywords: دوکوساهگزائنوئیک اسید; Randomized controlled trial; fetal programming; asthma; allergies; long-chain n-3 polyunsaturated fatty acids; DHA; Docosahexaenoic acid; EPA; Eicosapentaenoic acid; HR; Hazard ratio; OR; Odds ratio; PUFA; Polyunsaturated fatty acid; RCT; Randomized contr